Skip to content

Using Mobile applications studying the patient medication compliance to Cardiovascular drugs.

ASSESSMENT OF PATIENT MEDICATION ADHERENCE TO CARDIOVASCULAR DRUGS IN A SUPERSPECIALITY HOSPITAL USING MOBILE WHATSAPP

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/04/051649
Enrollment
1000
Registered
2023-04-17
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I52- Other heart disorders in diseasesclassified elsewhere

Interventions

Intervention1: NIL: NIL

Sponsors

Kamaleswari
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Both male and female patients above 18 years. 2.Cardiac Patient who underwent Interventional and or surgical procedures and preferred medical therapy, were included in the study. 3.Patients prescribed at least 1 cardiovascular medication, which may have include antihypertensives (β-blockers, calcium antagonists, diuretics, angiotensin converting enzyme inhibitors, and angiotensin II receptor antagonists), antihyperlipidemics (statins), or anticoagulants (direct-acting oral anticoagulants).

Exclusion criteria

Exclusion criteria: 1.Patients with co-morbid conditions such as chronic liver and kidney diseases, chronic obstructive pulmonary diseases, malignancy, and collagen vascular diseases were excluded from the study. 2.Patients who were not able to give written informed consent will be excluded.

Design outcomes

Primary

MeasureTime frame
Percentage reduction in cardiovascular events, adherence rate and overall long-term health and well-being.Timepoint: weekly, 6m and 1 year followup

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactSenthilraj R

Dr.MGR Educational and Research Institute

senthilraj.pharm@drmgrdu.ac.in914426800345

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026